A third hypothesis is that platelet-derived growth factor, which is produced by platelets, could boost cancer growth. Some combination of these mechanisms may turn out to be the link between high platelet count and higher rates of death from renal cell carcinoma. The IL-6 could be increasing the platelet count. The platelets could be making platelet-derived growth factor, which could be feeding the tumor. Renal cell carcinoma primarily occurs in adults between 50 and 70 years old, and men are twice as likely as women to be diagnosed.
Radical nephrectomy is the standard treatment.
All Rights Reserved.